Results

Total Results: 784 records

Showing results for "buprenorphine".

81. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=238
    January 01, 2024 - Practice Patterns Samples H , Williams AR , Olfson M Risk factors for discontinuation of buprenorphine … The purpose of this study was to examine duration of buprenorphine treatment for opioid use disorder … ; their sample included adults aged 18-64 years who had an OUD diagnosis 6 months before initiating buprenorphine … More than 1/4 of the sample discontinued buprenorphine in the first month of treatment, and most of the … Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state

82. Recent Data Analyses | Agency for Healthcare Research and Quality
    pbrn.ahrq.gov/opioids/data/analyses.html
    November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268 Price elasticity of demand for buprenorphine

83. Recent Data Analyses | Agency for Healthcare Research and Quality
    pcmh.ahrq.gov/opioids/data/analyses.html
    November 01, 2022 - prepublication, 24 December 2019. doi: 10.1016/j.addbeh.2019.106268 Price elasticity of demand for buprenorphine

84. Recommendation: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-screening
    June 09, 2020 - long-term use of opioid agonists, the US Food and Drug Administration (FDA) restricts approval for buprenorphine … was rare. 37 , 38 Seven trials assessed the opioid agonist methadone, the partial opioid agonist buprenorphine … these 2 opioid agonists (monitored for 4-12 months), use of methadone and sublingual or implantable buprenorphine … A few trials found that buprenorphine was associated with better self-reported scores on quality of life … Constipation was significantly more common in buprenorphine users than in control groups.

85. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=448
    January 01, 2024 - Determinants of Health, Obesity Turner L , Kruszewski SP , Alexander GC Trends in the use of buprenorphine … This study used descriptive statistics to examine trends in buprenorphine utilization from 2003 to 2013 … The use of buprenorphine products to treat opioid dependence has increased significantly and has shifted … Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013.

86. Opioid Treatments for Chronic Pain | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/opioids-chronic-pain/protocol
    February 27, 2019 - used (e.g., are there differences between pure opioid agonists and partial opioid agonists such as buprenorphine … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone

87. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=407
    January 01, 2024 - Elderly, Injuries and Wounds Kao DP , Haigney MC , Mehler PS Arrhythmia associated with buprenorphine … corrected QT interval prolongation or torsade de pointes to the US Food and Drug Administration between buprenorphine … countries, methadone is associated with disproportionate reporting of cardiac arrhythmias, whereas buprenorphine … Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.

88. Appendix-D-Surveillance-Report-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-d-surveillance-report-1.xlsx
    September 30, 2015 - cardiac or pulmonary issues; homeless or on parole; current medication contraindicated with methadone or buprenorphine … ; history of methadone/buprenorphine maintenance; pregnant; liver disease (note: from Neumann 2013) A … Sublingual buprenorphine / naloxone (8/2 to 16/4 mg daily) (10 assigned, 4 f/u) B. … 50 morphine milligram equivalents; excluded cancer, hospice, palliative care, and those prescribed buprenorphine

89. App-D-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
    September 30, 2015 - cardiac or pulmonary issues; homeless or on parole; current medication contraindicated with methadone or buprenorphine … ; history of methadone/buprenorphine maintenance; pregnant; liver disease (note: from Neumann 2013) A … Sublingual buprenorphine / naloxone (8/2 to 16/4 mg daily) (10 assigned, 4 f/u) B. … 50 morphine milligram equivalents; excluded cancer, hospice, palliative care, and those prescribed buprenorphine

90. Opioid Treatments for Chronic Pain Research Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
    December 19, 2018 - used (e.g., are there differences between pure opioid agonists and partial opioid agonists such as buprenorphine … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone … (buprenorphine or codeine or fentanyl or hydrocodone or hydromorphone or methadone or morphine or oxycodone

91. JAMA (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/UaT8AVUSVQwSduNs8TA-_e
    June 09, 2020 - • Based on lack of evidence that these interventions cause serious adverse events and evidence that buprenorphine … long-term use of opioid ago- nists, the US Food and Drug Administration (FDA) restricts approval for buprenorphine … A few trials found that buprenorphine was associ- ated with better self-reported scores on quality of … the harms of screening in adults or adolescents.12 Pharmacotherapy Eleven naltrexone trials and 4 buprenorphine … Constipation was significantly more common in buprenorphine users than in control groups.

92. Sb260-Appendix (pdf file)
    hcup-us.ahrq.gov/reports/statbriefs/sb260-appendix.pdf
    June 15, 2020 - Hospitals, American Hospital Association www.ahadata.co m/aha-annual- survey-database 2016 Buprenorphine … provider availability Number of practitioners waived to provide buprenorphine for the treatment … of opioid use disorder per 100,000 county population1 Buprenorphine Treatment Practitioner Locator

93. A Rapid Evidence Review of Retention Strategies for Medications for Addiction Treatment (MAT) in Adults with Opioid Use Disorder | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-protocol
    May 08, 2019 - Food and Drug Administration approved medications for OUD- methadone, buprenorphine, and extended-release … Participants/Population Include: nonpregnant adults with OUD who are involved in MAT (buprenorphine

94. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=98
    January 01, 2024 - Quality, Patient Safety, Quality Improvement, Quality of Care Lillie KM , Shaw J , Jansen KJ Buprenorphine … The objective of this study was to identify variables associated with buprenorphine/naloxone retention … younger patients and those with co-occurring substance use remained at higher risk of discontinuing buprenorphine … Buprenorphine/naloxone for opioid use disorder among Alaska Native and American Indian people.

95. App-D-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - cardiac or pulmonary issues; homeless or on parole; current medication contraindicated with methadone or buprenorphine … ; history of methadone/buprenorphine maintenance; pregnant; liver disease (note: from Neumann 2013) A … Sublingual buprenorphine / naloxone (8/2 to 16/4 mg daily) (10 assigned, 4 f/u) B. … 50 morphine milligram equivalents Exclusion: cancer, hospice, palliative care, and those prescribed buprenorphine

96. Topic Brief on Mental Health Treatments in Pregnancy (pdf file)
    effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-disposition-mental-health-pregnancy_0.pdf
    June 01, 2021 - Maternal Buprenorphine Dose at Delivery and Its Relationship to Neonatal Outcomes. … Does concurrent in utero exposure to buprenorphine and antidepressant medications influence the course … Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infants. … Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. … Buprenorphine and naloxone compared with methadone treatment in pregnancy.

97. Edwin Melnick, MD, MHS | CDSiC
    cdsic.ahrq.gov/cdsic/Edwin-Melnick
    January 01, 2013 - disseminate, implement, and test a user-centered decision support system to facilitate ED-initiation of buprenorphine

98. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=57
    January 01, 2024 - MK , Drake C , Saloner B Medicaid managed care: access to primary care providers who prescribe buprenorphine … This study examined variation in access to in-network buprenorphine-prescribing primary care providers … Approximately 32.2% of Medicaid enrollees had fewer than one in-network network buprenorphine-prescribing … There was on average a greater number of in-network buprenorphine-prescribing primary care providers … Medicaid managed care: access to primary care providers who prescribe buprenorphine.

99. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=85
    January 01, 2024 - Sussman AL , Crawford JN , Brakey HR Use of a benchmark tracking assessment to support expansion of buprenorphine … Barriers to the expansion of opioid use disorder (OUD) treatment in primary care using buprenorphine … study to examine the impact of provider participation in an online intervention to support expansion of buprenorphine … Use of a benchmark tracking assessment to support expansion of buprenorphine for treatment of opioid

100. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=169
     January 01, 2024 - Author: H Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine … Although buprenorphine treatment reduces risk of overdose and death in opioid use disorder, most patients … In this study, adverse health outcomes following buprenorphine discontinuation were compared among patients … Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine